Literature DB >> 24048223

Quality of life in the follow-up of uveal melanoma patients after CyberKnife treatment.

Annemarie Klingenstein1, Christoph Fürweger, Martin M Nentwich, Ulrich C Schaller, Paul I Foerster, Berndt Wowra, Alexander Muacevic, Kirsten H Eibl.   

Abstract

To assess quality of life in uveal melanoma patients within the first and second year after CyberKnife radiosurgery. Overall, 91 uveal melanoma patients were evaluated for quality of life through the Short-form (SF-12) Health Survey at baseline and at every follow-up visit over 2 years after CyberKnife radiosurgery. Statistical analysis was carried out using SF Health Outcomes Scoring Software and included subgroup analysis of patients developing secondary glaucoma and of patients maintaining a best corrected visual acuity (BCVA) of the treated eye of 0.5 log(MAR) or better. Analysis of variance, Greenhouse-Geisser correction, Student's t-test, and Fisher's exact test were used to determine statistical significance. Physical Functioning (PF) and Role Physical (RP) showed a significant decrease after CyberKnife radiosurgery, whereas Mental Health (MH) improved (P=0.007, P<0.0001 and P=0.023). MH and Social Functioning (SF) increased significantly (P=0.0003 and 0.026) in the no glaucoma group, MH being higher compared with glaucoma patients (P=0.02). PF and RP were significantly higher in patients with higher BCVA at the second follow-up (P=0.02). RP decreased in patients with BCVA<0.5 log(MAR) (P=0.013). Vitality (VT) increased significantly in patients whose BCVA could be preserved (P=0.031). Neither tumor localization nor size influenced the development of secondary glaucoma or change in BCVA. Although PF and RP decreased over time, MH improved continuously. Prevention of secondary glaucoma has a significant influence on both SF and MH, whereas preservation of BCVA affects VT. Emotional stability throughout follow-up contributes positively toward overall quality of life. CyberKnife radiosurgery may contribute to attenuation of emotional distress in uveal melanoma patients.

Entities:  

Mesh:

Year:  2013        PMID: 24048223     DOI: 10.1097/CMR.0000000000000023

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  7 in total

Review 1.  [CyberKnife®: new treatment option for uveal melanoma].

Authors:  J M Mor; R Semrau; W Baus; K R Koch; F Schaub; C Cursiefen; S Marnitz; L M Heindl
Journal:  Ophthalmologe       Date:  2018-04       Impact factor: 1.059

Review 2.  Predictors of emotional distress in uveal melanoma survivors: a systematic review.

Authors:  Cari Davies; Stephen Lloyd Brown; Peter Fisher; Laura Hope-Stone; Debra Fisher; Andrew Morgan; Mary Gemma Cherry
Journal:  Eye (Lond)       Date:  2022-08-08       Impact factor: 4.456

3.  Screening for Predictive Parameters Requiring Psycho-Oncological Intervention via the National Comprehensive Cancer Network Distress Thermometer in the Follow-Up of Uveal Melanoma Patients.

Authors:  Annemarie Klingenstein; Christina Samel; Aylin Garip-Kuebler; Siegfried G Priglinger; Paul I Foerster
Journal:  Clin Ophthalmol       Date:  2020-11-09

4.  Quality of life in the follow-up of uveal melanoma patients after enucleation in comparison to CyberKnife treatment.

Authors:  A Klingenstein; C Fürweger; A K Mühlhofer; S F Leicht; U C Schaller; A Muacevic; B Wowra; C Hintschich; K H Eibl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-16       Impact factor: 3.117

5.  Psychosocial impact of prognostic genetic testing in uveal melanoma patients: a controlled prospective clinical observational study.

Authors:  Marietta Lieb; Sefik Tagay; Anja Breidenstein; Tobias Hepp; Claudia H D Le Guin; Jennifer Scheel; Dietmar R Lohmann; Norbert Bornfeld; Martin Teufel; Yesim Erim
Journal:  BMC Psychol       Date:  2020-01-31

6.  Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma.

Authors:  Johannes Gollrad; Christopher Rabsahl; Aline-Isabel Riechardt; Jens Heufelder; Andrea Stroux; Ute Goerling; Antonia Joussen; Volker Budach; Dirk Boehmer
Journal:  Radiat Oncol       Date:  2021-09-08       Impact factor: 3.481

7.  Psychosocial impact of prognostic genetic testing in the care of uveal melanoma patients: protocol of a controlled prospective clinical observational study.

Authors:  Yesim Erim; Jennifer Scheel; Anja Breidenstein; Claudia Hd Metz; Dietmar Lohmann; Hans-Christoph Friederich; Sefik Tagay
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.